Touyun Biotech Group Limited logo

Touyun Biotech Group Limited

1332.HK

HKSEConsumer CyclicalPackaging & Containers

Latest quote

HK$0.15

+HK$0.004 · +2.74%

Aug 21, 3:59 PM HKT

1332.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Hong Kong, the People's Republic of China, Europe, North and South America, and other international territories. The company's operations are divided into four main business segments. The QR Code Business provides comprehensive solutions, including QR codes for product packaging and advertising display services. The Packaging Products segment specializes in creating and selling items such as luxury watch and jewelry boxes, eyewear cases, various bags and pouches, and retail display units. The Treasury Investment segment is engaged in the investment and trading of securities, alongside offering financial services like money lending, placing and underwriting, securities brokerage, asset management, and margin financing. Additionally, the Chlamydomonas Reinhardtii Product Business segment focuses on cultivating and marketing Chlamydomonas reinhardtii micro-algae and associated products. Beyond these core activities, the group also offers business intelligence IT solutions, online advertising display, and corporate management services. Established in 1989 and headquartered in Wan Chai, Hong Kong, the company transitioned to its current name, Touyun Biotech Group Limited, in May 2021, having previously been known as China Touyun Tech Group Limited.

Industry
Packaging & Containers
Sector
Consumer Cyclical
Headquarters
HK
CEO
Liang Wang
Listed since
Jul 12, 2012
Employees
296

Market position

52-week range

Current HK$0.15

Open
HK$0.15
Previous close
HK$0.146
Volume
1.56K
0× average
Average volume
1.58M
Average daily volume
Market cap
420.84M HKD
Beta
-0.6
Market reference 1
50-day average
HK$0.1438
+4.31% above average
200-day average
HK$0.1741
-13.82% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.89B HKD
EV / EBITDA
-39.51×
Earnings yield
1.81%
Free cash flow yield
-2.20%

Profitability & efficiency

Return on equity
-52.45%
Return on assets
4.32%
Return on invested capital
-13.62%

Financial health

Current ratio
0.17×
Altman Z-score
-5.46
Piotroski F-score
2 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends63%-9%-81%-153%Gross margin, FY2021: 37.76%Gross margin, FY2022: 38.03%Gross margin, FY2023: 28.50%Gross margin, FY2024: 45.05%Gross margin, FY2025: 24.22%Operating margin, FY2021: -11.00%Operating margin, FY2022: -13.45%Operating margin, FY2023: -45.47%Operating margin, FY2024: -42.25%Operating margin, FY2025: -89.81%Net margin, FY2021: -25.73%Net margin, FY2022: -62.71%Net margin, FY2023: -135.39%Net margin, FY2024: -55.08%Net margin, FY2025: 40.02%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 37.76%. Gross margin FY2022 38.03%. Gross margin FY2023 28.50%. Gross margin FY2024 45.05%. Gross margin FY2025 24.22%. Operating margin FY2021 -11.00%. Operating margin FY2022 -13.45%. Operating margin FY2023 -45.47%. Operating margin FY2024 -42.25%. Operating margin FY2025 -89.81%. Net margin FY2021 -25.73%. Net margin FY2022 -62.71%. Net margin FY2023 -135.39%. Net margin FY2024 -55.08%. Net margin FY2025 40.02%.

Income trends

Revenue

66.97M HKD-58.13%

Operating income

−60.14M HKD+11.00%

Net income

26.8M HKD+114.91M HKD
Income trends across reported periods374.3M HKD140.4M HKD−93.51M HKD−327.42M HKDRevenue, FY2021: 283.51M HKDRevenue, FY2022: 315.83M HKDRevenue, FY2023: 198.64M HKDRevenue, FY2024: 159.97M HKDRevenue, FY2025: 66.97M HKDOperating income, FY2021: −31.18M HKDOperating income, FY2022: −42.47M HKDOperating income, FY2023: −90.32M HKDOperating income, FY2024: −67.58M HKDOperating income, FY2025: −60.14M HKDNet income, FY2021: −72.95M HKDNet income, FY2022: −198.07M HKDNet income, FY2023: −268.94M HKDNet income, FY2024: −88.11M HKDNet income, FY2025: 26.8M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 283.51M HKD. Revenue FY2022 315.83M HKD. Revenue FY2023 198.64M HKD. Revenue FY2024 159.97M HKD. Revenue FY2025 66.97M HKD. Operating income FY2021 −31.18M HKD. Operating income FY2022 −42.47M HKD. Operating income FY2023 −90.32M HKD. Operating income FY2024 −67.58M HKD. Operating income FY2025 −60.14M HKD. Net income FY2021 −72.95M HKD. Net income FY2022 −198.07M HKD. Net income FY2023 −268.94M HKD. Net income FY2024 −88.11M HKD. Net income FY2025 26.8M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue66.97M HKD159.97M HKD198.64M HKD315.83M HKD283.51M HKD
Cost of goods sold50.75M HKD87.9M HKD142.04M HKD195.71M HKD176.45M HKD
Gross profit16.22M HKD72.07M HKD56.6M HKD120.12M HKD107.05M HKD
Research and development20.92M HKD22.29M HKD20.28M HKD23.34M HKD
Selling, general, and administrative76.36M HKD115.89M HKD124.63M HKD142.3M HKD144.74M HKD
Operating expenses76.36M HKD118.77M HKD146.92M HKD162.58M HKD168.54M HKD
Interest income21K HKD80K HKD140K HKD85K HKD173K HKD
Interest expense21.18M HKD10.11M HKD7.43M HKD21.65M HKD17.14M HKD
Depreciation and amortization12.28M HKD18.74M HKD36.59M HKD33.14M HKD22.7M HKD
Operating income−60.14M HKD−67.58M HKD−90.32M HKD−42.47M HKD−31.18M HKD
Net income26.8M HKD−88.11M HKD−268.94M HKD−198.07M HKD−72.95M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0.01

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates-0-0.04-0.07-0.11Q2 '21Q4 '21Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25
Q2 2021, reported Jun 30, 2021: actual -0.022, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual -0.004, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Aug 26, 2022: actual -0.031, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 28, 2023: actual -0.039, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 26, 2023: actual -0.03, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 29, 2024: actual -0.066, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 23, 2024: actual -0.017, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual -0.014, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates173.65M138.07M102.49M66.91MQ2 '21Q4 '21Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25
Q2 2021, reported Jun 30, 2021: actual 136.76M HKD, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual 146.75M HKD, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Aug 26, 2022: actual 166.29M HKD, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 28, 2023: actual 149.54M HKD, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 26, 2023: actual 103.37M HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 29, 2024: actual 95.27M HKD, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 23, 2024: actual 74.27M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual 85.7M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock split

Effective Aug 12, 2019

1:4

Stock split

Effective May 20, 2015

5:4

Stock split

Effective Jan 13, 2015

10:1

Stock split

Effective Jan 5, 2015

2:1

1332.HK peers

ETFs holding 1332.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 1332.HK

research.disclaimer